{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:51:12Z","timestamp":1781290272132,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Soft tissue sarcomas (STS) account for less than 1% of all malignancies. Approximately 50% of the patients develop metastases with limited survival in the course of their disease. For those patients, palliative treatment aiming at symptom relief and improvement of quality of life is most important. However, data on symptom burden and palliative intervention are limited in STS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Our study evaluates the effectiveness of a palliative care intervention on symptom relief and quality of life in STS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design\/setting<\/jats:title>\n                <jats:p>We retrospectively analysed 53 inpatient visits of 34 patients with advanced STS, admitted to our palliative care unit between 2012 and 2018.<\/jats:p>\n                <jats:p>Symptom burden was measured with a standardised base assessment questionnaire at admission and discharge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median disease duration before admission was 24\u2009months, 85% of patients had metastases. The predominant indication for admission was pain, weakness and fatigue. Palliative care intervention led to a significant reduction of pain: median NRS for acute pain was reduced from 3 to 1 (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), pain within the last 24\u2009h from 5 to 2 (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001) and of the median MIDOS symptom score: 18 to 13 (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001). Also, the median stress level, according to the distress thermometer, was reduced significantly: 7.5 to 5 (<jats:italic>p<\/jats:italic>\u00a0=\u20090.027).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data underline that specialised palliative care intervention leads to significant symptom relief in patients with advanced STS. Further efforts should aim for an early integration of palliative care in these patients focusing primarily on the identification of subjects at high risk for severe symptomatic disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-020-00702-1","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T14:03:52Z","timestamp":1610633032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma \u2013 a single-centre retrospective analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"F.","family":"Brandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"Striefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmiester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"M\u00e4rdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Koulaxouzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Thuss-Patience","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fl\u00f6rcken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"issue":"2","key":"702_CR1","first-page":"95","volume":"46","author":"VY Jo","year":"2014","unstructured":"Jo VY, Fletcher CDM. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology (Phila). 2014 Feb;46(2):95\u2013104.","journal-title":"Pathology (Phila)."},{"issue":"1","key":"702_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin."},{"key":"702_CR3","unstructured":"Cancer of soft tissue including heart - Cancer Stat Facts. SEER. [cited 2019 Dec 1]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/soft.html."},{"issue":"4","key":"702_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, Hartmann JT, Sch\u00f6ffski P, Blay J-Y, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415\u201323.","journal-title":"Lancet Oncol."},{"key":"702_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/740279","volume":"2012","author":"P Reichardt","year":"2012","unstructured":"Reichardt P, Leahy M, Garcia Del Muro X, Ferrari S, Martin J, Gelderblom H, et al. Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma. 2012;2012:740279.","journal-title":"Sarcoma."},{"issue":"3","key":"702_CR6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jpainsymman.2016.10.357","volume":"53","author":"N Gough","year":"2017","unstructured":"Gough N, Koffman J, Ross JR, Riley J, Judson I. Symptom Burden in Advanced Soft-Tissue Sarcoma. J Pain Symptom Manage. 2017;53(3):588\u201397.","journal-title":"J Pain Symptom Manage."},{"key":"702_CR7","doi-asserted-by":"crossref","unstructured":"Gough NJ, Smith C, Ross JR, Riley J, Judson I. Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma [Internet]. Sarcoma. 2011 [cited 2018 Sep 16]. Available from: https:\/\/www.hindawi.com\/journals\/sarcoma\/2011\/325189\/.","DOI":"10.1155\/2011\/325189"},{"key":"702_CR8","unstructured":"WHO | WHO Definition of Palliative Care. WHO. [cited 2019 Dec 1]. Available from: https:\/\/www.who.int\/cancer\/palliative\/definition\/en\/."},{"issue":"6","key":"702_CR9","volume":"12","author":"MW Haun","year":"2017","unstructured":"Haun MW, Estel S, R\u00fccker G, Friederich H-C, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;12(6):CD011129.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"702_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1191\/0269216303pm794oa","volume":"17","author":"B Jack","year":"2003","unstructured":"Jack B, Hillier V, Williams A, Oldham J. Hospital based palliative care teams improve the symptoms of cancer patients. Palliat Med. 2003 Sep;17(6):498\u2013502.","journal-title":"Palliat Med."},{"issue":"8","key":"702_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1089\/jpm.2018.0415","volume":"22","author":"H Kawashima","year":"2019","unstructured":"Kawashima H, Ariizumi T, Yamagishi T, Ogose A, Ikoma M, Hotta T, et al. Symptom Burden and End-of-Life Palliative Treatments during the Last Two Weeks of Life in Patients with Advanced Musculoskeletal Sarcoma. J Palliat Med. 2019;22(8):908\u201314.","journal-title":"J Palliat Med."},{"key":"702_CR12","doi-asserted-by":"crossref","unstructured":"Gough N, Koffman J, Ross JR, Riley J, Judson I. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma. PLoS ONE. 2019;14(9) Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6762058\/.","DOI":"10.1371\/journal.pone.0210731"},{"issue":"6","key":"702_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014614","volume":"7","author":"M Schuler","year":"2017","unstructured":"Schuler M, Richter S, Ehninger G, Bornh\u00e4user M, Hentschel L. A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma. BMJ Open. 2017;7(6):e014614.","journal-title":"BMJ Open."},{"key":"702_CR14","doi-asserted-by":"crossref","unstructured":"Hentschel L, Richter S, Kopp H-G, Kasper B, Kunitz A, Gr\u00fcnwald V, et al. Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG). BMJ Open. 2020 Aug 27;10(8). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7454199\/.","DOI":"10.1136\/bmjopen-2019-035546"},{"key":"702_CR15","unstructured":"Dokumentationshilfen. [cited 2020 Sep 30]. Available from: https:\/\/www.dgpalliativmedizin.de\/category\/5-neu-ops-8-98e-dokumentationshilfen.html."},{"key":"702_CR16","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 [cited 2020 Sep 30]; Available from: https:\/\/www.scienceopen.com\/document?vid=1125a396-3edb-4eed-9421-39241e862ed3."},{"key":"702_CR17","unstructured":"Riba MB, Donovan KA, Andersen B, Braun Ii, Breitbart WS, Brewer BW, et al. Distress Management, Version 3.2019. J Natl Compr Cancer Netw JNCCN. 2019;17(10):1229\u20131249."},{"issue":"4","key":"702_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s004820070028","volume":"14","author":"L Radbruch","year":"2000","unstructured":"Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, H\u00f6rmann E. MIDOS--validation of a minimal documentation system for palliative medicine. Schmerz Berl Ger. 2000;14(4):231\u20139.","journal-title":"Schmerz Berl Ger."},{"key":"702_CR19","doi-asserted-by":"crossref","unstructured":"Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;(37):714\u201323.","DOI":"10.1200\/EDBK_175474"},{"key":"702_CR20","doi-asserted-by":"crossref","unstructured":"Finn L, Malhotra S. The Development of Pathways in Palliative Medicine: Definition, Models, Cost and Quality Impact. Healthc Basel Switz. 2019;7(1).","DOI":"10.3390\/healthcare7010022"},{"issue":"11","key":"702_CR21","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/S1470-2045(18)30415-7","volume":"19","author":"S Kaasa","year":"2018","unstructured":"Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, et al. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol. 2018;19(11):e588\u2013653.","journal-title":"Lancet Oncol."},{"issue":"8","key":"702_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early Palliative Care for Patients with Metastatic Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med."},{"issue":"3","key":"702_CR23","first-page":"99","volume":"4","author":"MP Davis","year":"2015","unstructured":"Davis MP, Temel JS, Balboni T. Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4(3):99\u2013121.","journal-title":"Ann Palliat Med."},{"key":"702_CR24","doi-asserted-by":"crossref","unstructured":"Qureshi D, Tanuseputro P, Perez R, Pond GR, Seow H-Y. Early initiation of palliative care is associated with reduced late-life acute-hospital use: A population-based retrospective cohort study. Palliat Med. 2019;33(2):150\u20139.","DOI":"10.1177\/0269216318815794"},{"issue":"1","key":"702_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","volume":"35","author":"BR Ferrell","year":"2017","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(1):96\u2013112.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"702_CR26","doi-asserted-by":"crossref","unstructured":"Simon S, Pralong A, Radbruch L, Bausewein C, Voltz R. Clinical practice guideline: The palliative care of patients with incurable cancers. Dtsch Arztebl Int 2020. 2020 [cited 2020 Mar 29];(117: 108\u201315). Available from: https:\/\/www.aerzteblatt.de\/archiv\/212419\/Palliativversorgung-von-Patienten-mit-einer-nichtheilbaren-Krebserkrankung.","DOI":"10.3238\/arztebl.2020.0108"},{"key":"702_CR27","doi-asserted-by":"crossref","unstructured":"Zimmermann C, Ryan S, Hannon B, Saltman A, Rodin G, Mak E, et al. Team-based outpatient early palliative care: a complex cancer intervention. BMJ Support Palliat Care. 2019.","DOI":"10.1136\/bmjspcare-2019-001903"},{"key":"702_CR28","doi-asserted-by":"crossref","unstructured":"Hutt E, Silva AD, Bogart E, Lay-Diomande SL, Pannier D, Delaine-Clisant S, et al. Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial. BMJ Open. 2018 Jan 1 [cited 2020 Jan 4];8(1). Available from: https:\/\/bmjopen.bmj.com\/content\/8\/1\/e015904.","DOI":"10.1136\/bmjopen-2017-015904"},{"issue":"3","key":"702_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30060-3","volume":"19","author":"G Vanbutsele","year":"2018","unstructured":"Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R, et al. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol. 2018;19(3):394\u2013404.","journal-title":"Lancet Oncol."}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-020-00702-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12904-020-00702-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-020-00702-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T14:05:49Z","timestamp":1610633149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-020-00702-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1186\/s12904-020-00702-1","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Patients were included with institutional review board approval and written patient informed consent in accordance with the local ethical guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}